---
title: "《新股》华芢生物－B 暗盘收报 38.42 元 高上市价 0.6%"
description: "华芢生物－B 在辉立交易平台暗盘收报 38.42 元，高上市价 0.6%，成交 145 万股，涉资 6,020 万元；在富途交易平台暗盘收报 40.4 元，高上市价 5.8%，成交 78.24 万股，涉资 3,765.55 万元。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/270290927.md"
published_at: "2025-12-19T10:35:01.000Z"
---

# 《新股》华芢生物－B 暗盘收报 38.42 元 高上市价 0.6%

> 华芢生物－B 在辉立交易平台暗盘收报 38.42 元，高上市价 0.6%，成交 145 万股，涉资 6,020 万元；在富途交易平台暗盘收报 40.4 元，高上市价 5.8%，成交 78.24 万股，涉资 3,765.55 万元。

根据辉立交易平台显示，明天挂牌的华芢生物－B(02396.HK) 暗盘高开 55% 报 59.2 元，最高/低分别见 60.2/34.4 元，收报 38.42 元，较上市价高 0.6% 或 0.22 元，成交 145 万股，涉资 6,020 万元。不计手续费，每手 200 股，账面赚 44 元。

根据富途交易平台显示，明天挂牌的华芢生物－B(02396.HK) 暗盘高开 57.1% 报 60 元，最高/低分别见 72.15/38.2 元，收报 40.4 元，较上市价高 5.8% 或 2.20 元，成交 78.24 万股，涉资 3,765.55 万元。不计手续费，每手 200 股，账面赚 440 元。

### Related Stocks

- [03588.HK - 富途控股-W](https://longbridge.com/zh-CN/quote/03588.HK.md)
- [FUTU.US - 富途控股](https://longbridge.com/zh-CN/quote/FUTU.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| ZAWYA-PRESSR: EPAA in Sharjah launches strategic recommendations for biodiversity conservation and nature protection | The Environment and Protected Areas Authority in Sharjah (EPAA) has launched strategic recommendations for biodiversity  | [Link](https://longbridge.com/zh-CN/news/275432705.md) |
| Godavari Biorefineries Dec-Quarter Consol PAT 82.5 Million Rupees | Godavari Biorefineries Ltd :GODAVARI BIOREFINERIES DEC-QUARTER CONSOL PAT 82.5 MILLION RUPEESGODAVARI BIOREFINERIES LTD  | [Link](https://longbridge.com/zh-CN/news/275909082.md) |
| INmune Bio: Biomarker-Driven Alzheimer’s Trial Design and Pipeline Catalysts Underpin Buy Rating | Analyst Jason McCarthy of Maxim Group has maintained a Buy rating on Inmune Bio with a price target of $8.00. This ratin | [Link](https://longbridge.com/zh-CN/news/275941900.md) |
| Biotalys plant strategische Fokussierung auf Kernprodukte, Kostensenkung und Entwicklung von Biofungiziden | Biotalys NV is strategically refocusing its operations to concentrate on key programs and streamline its operational str | [Link](https://longbridge.com/zh-CN/news/275304861.md) |
| Cumulus Neuroscience entered customer relationship with Shionogi to advance novel cognitive biomarkers | Cumulus Neuroscience entered customer relationship with Shionogi to advance novel cognitive biomarkers | [Link](https://longbridge.com/zh-CN/news/275495340.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
